A self-taught entrepreneur, investor, and futurist, Jason Hope is an active member of the entrepreneurial community. Passionate about improving health, science, longevity, and innovation, he is deeply engaged with the healthcare industry, focusing his attention on aging-related issues.
Jason Hope is an activist investor. In the past decade, several prominent health issues have received increased media coverage, including the potential to cure diseases such as cancer and Parkinson’s disease. Stem cells have also been touted as an effective treatment for many medical conditions, ranging from degenerative brain diseases to autoimmune disorders, cardiovascular problems, eye ailments, and even cosmetic improvements.
Although much research remains to be done before scientists can confirm these claims definitively, the growing interest in stem cells is not likely to diminish any time soon as Jason Hope recalls. Scientists recently extracted stem cells from fertilized eggs taken directly from women. These stem cells can develop into any cell in your body, including skin, blood, brain, muscle, and fat cells. These stem cells may be vital in curing conditions such as cancer, diabetes, and cardiac problems.
Stem cells also present an opportunity to create new organs and tissues needed for transplants. Since embryonic stem cells cannot cause harm to patients, they have fewer ethical concerns than adult stem cells. Furthermore, Jason Hope adds, embryonic stem cells do not pose the same risk of tumor formation because they come from fertilized ova rather than adult tissue. Hope, who has dedicated much of his philanthropy toward the medical industry through organizations such as the SENS Foundation, recognizes that most stem cells are rightfully considered experimental.
This, until adequate research, testing, and implantation can occur. As an expert in longevity, and the championing thereof, the activist investor understands the importance of ensuring that new stem cell therapies are tested thoroughly before being made widely available to patients. Due to the intense skepticism felt among the public regarding the efficacy of stem cell therapies, activist investor Jason Hope strongly advocates the slow and steady approach essential if these procedures are ever to come to fruition.